z-logo
open-access-imgOpen Access
The Tumor Suppressor Hace1 Is a Critical Regulator of TNFR1-Mediated Cell Fate
Author(s) -
Luigi Tortola,
Roberto Nitsch,
Mathieu J.M. Bertrand,
Melanie Kögler,
Younes Redouane,
I. Kozieradzki,
Iris Uribesalgo,
Lilian M. Fennell,
Mads Daugaard,
Helene Klug,
Gerald Wirnsberger,
Reiner Wimmer,
Thomas Perlot,
Renu Sarao,
Shuan Rao,
Toshikatsu Hanada,
Nozomi Takahashi,
Elisabeth Kernbauer,
Duygu Demiröz,
Michaela Lang,
Giulio SupertiFurga,
Thomas Decker,
Andrea Pichler,
Fumiyo Ikeda,
Guido Kroemer,
Peter Vandenabeele,
Poul H. Sorensen,
Josef Penninger
Publication year - 2016
Publication title -
cell reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.264
H-Index - 154
eISSN - 2639-1856
pISSN - 2211-1247
DOI - 10.1016/j.celrep.2016.04.032
Subject(s) - regulator , cell fate determination , suppressor , microbiology and biotechnology , chemistry , master regulator , cell , biology , biochemistry , transcription factor , gene
The HECT domain E3 ligase HACE1 has been identified as a tumor suppressor in multiple cancers. Here, we report that HACE1 is a central gatekeeper of TNFR1-induced cell fate. Genetic inactivation of HACE1 inhibits TNF-stimulated NF-κB activation and TNFR1-NF-κB-dependent pathogen clearance in vivo. Moreover, TNF-induced apoptosis was impaired in hace1 mutant cells and knockout mice in vivo. Mechanistically, HACE1 is essential for the ubiquitylation of the adaptor protein TRAF2 and formation of the apoptotic caspase-8 effector complex. Intriguingly, loss of HACE1 does not impair TNFR1-mediated necroptotic cell fate via RIP1 and RIP3 kinases. Loss of HACE1 predisposes animals to colonic inflammation and carcinogenesis in vivo, which is markedly alleviated by genetic inactivation of RIP3 kinase and TNFR1. Thus, HACE1 controls TNF-elicited cell fate decisions and exerts tumor suppressor and anti-inflammatory activities via a TNFR1-RIP3 kinase-necroptosis pathway.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom